Finance

Beta
Lists
SPARC:NSE
Sun Pharma Advanced Research Co Ltd
203,99 INR
+3,88%
(+7,62) 1D
2 ივნ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SPARC...
Open
197,00 INR
High
207,38 INR
Low
194,10 INR
Mkt. cap
66,20 მლრდ.
Avg. vol.
9,40 მლნ.
Volume
6,98 მლნ.
P/E ratio
4,26
52-wk high
248,75 INR
52-wk low
108,00 INR
EPS
47,86 INR
Shares outstanding
255,99 მლნ.
No. of employees
316
Open
197,00 INR
High
207,38 INR
Low
194,10 INR
Mkt. cap
66,20 მლრდ.
Avg. vol.
9,40 მლნ.
Volume
6,98 მლნ.
P/E ratio
4,26
52-wk high
248,75 INR
52-wk low
108,00 INR
EPS
47,86 INR
Shares outstanding
255,99 მლნ.
No. of employees
316
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
11 წუთის წინ
AI is carrying the S&P 500 rally: Chart of the Day
The Motley Fool
The Motley Fool
·
8 წუთის წინ
These 2 Dividend ETFs Are Beating the S&P 500 -- Which Should You Buy?
Trefis
Trefis
·
41 წუთის წინ
S&P 500 Stocks Trading At 52-Week Low
Seeking Alpha
Seeking Alpha
·
36 წუთის წინ
Since 2004, This Key Investor Indicator Hasn't Been This Low (SP500)
About Sun Pharma Advanced Research Co Ltd
CEO-
Employees316
Founded2006
Headquarters-
SectorPharmaceutical industry
Websitesparc.life
Last report
18 მაი. 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
18,53 მლრდ. / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
96,40 მლნ.
78,60 მლნ.
84,50 მლნ.
18,53 მლრდ.
Cost of goods sold
51,30 მლნ.
61,00 მლნ.
72,10 მლნ.
51,60 მლნ.
Cost of revenue
51,30 მლნ.
61,00 მლნ.
72,10 მლნ.
51,60 მლნ.
Research and development expenses
55,40 მლნ.
80,10 მლნ.
62,70 მლნ.
28,40 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
413,90 მლნ.
483,40 მლნ.
424,60 მლნ.
553,20 მლნ.
Operating expense
592,70 მლნ.
700,40 მლნ.
604,50 მლნ.
772,60 მლნ.
Total operating expenses
644,00 მლნ.
761,40 მლნ.
676,60 მლნ.
824,20 მლნ.
Operating income
-547,60 მლნ.
-682,80 მლნ.
-592,10 მლნ.
17,71 მლრდ.
Other non operating income
91,40 მლნ.
100,00 ათ.
-
18,00 მლნ.
EBT including unusual items
-518,10 მლნ.
-757,90 მლნ.
-803,50 მლნ.
17,61 მლრდ.
EBT excluding unusual items
-518,10 მლნ.
-757,90 მლნ.
-679,90 მლნ.
17,61 მლრდ.
Income tax expense
600,00 ათ.
600,00 ათ.
700,00 ათ.
-3,80 მლნ.
Effective tax rate
-0,12%
-0,08%
-0,09%
-0,02%
Other operating expenses
96,60 მლნ.
111,30 მლნ.
91,50 მლნ.
167,00 მლნ.
Net income
-518,70 მლნ.
-758,50 მლნ.
-804,20 მლნ.
17,61 მლრდ.
Net profit margin
-538,07%
-965,01%
-951,72%
95,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-61,90 მლნ.
-75,20 მლნ.
-87,80 მლნ.
-116,40 მლნ.
Net interest expenses
-61,90 მლნ.
-75,20 მლნ.
-87,80 მლნ.
-116,40 მლნ.
Depreciation and amortization charges
26,80 მლნ.
25,60 მლნ.
25,70 მლნ.
24,00 მლნ.
EBITDA
-526,25 მლნ.
-656,60 მლნ.
-570,75 მლნ.
17,73 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer